Table of Content - North America, Europe, And Australia Peanut Allergy Treatment Market

Peanut allergy is an allergic response by individual on exposure to peanuts. The most severe allergic reaction to peanuts is anaphylaxis a life-threatening whole-body response to an allergen. Anaphylaxis should be treated immediately with epinephrine (adrenaline), typically administered in an auto-injector. Diagnosing a peanut allergy can be complicated. Symptoms can vary from person to person, and a single individual may not always experience the same symptoms during every reaction.

Market Dynamics

Key players operating in the North America, Europe, and Australia peanut allergy treatment market are focusing on adoption of growth strategies such as product approval for the treatment of peanut allergy which are expected to drive market growth during the forecast period. For instance, In September 2021, COUR Pharmaceuticals, a pharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) accepted the company's Investigational New Drug (IND) application for evaluation of COUR's CNP-201 in a proof-of-concept (Phase 1 / 2) study in people who are allergic to peanuts. Moreover, increasing adoption of inorganic growth strategies by market players and government organizations is expected to drive the market growth over the forecast period. For instance, in December 2021, the National Health Service, U.K., announced that the department of health signed an agreement with Aimmune Therapeutics, Inc., a Nestlé Health Science company to provide Palforzia in the U.K. The U.K. will be the first country to receive Palforzia in Europe.

Key features of the study:

This report provides in-depth analysis of the North America, Europe, and Australia peanut allergy treatment market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the North America, Europe, and Australia peanut allergy treatment market based on the following parameters – Company Highlights, Products Portfolio, Key Highlights, Financial Performance, and Strategies
Key companies covered as a part of this study include, DBV Technologies DBV Technologies, Aimmune Therapeutics, Inc., Prota Therapeutics Pty Ltd., COUR Pharmaceuticals, BlueWillow Biologics, HAL Allergy B.V., Allergy Therapeutics PLC., Novartis AG, Regeneron Pharmaceuticals, Inc., Vedanta Biosciences, Inc., Cambridge Allergy Ltd. (Camallergy), Angany Inc., Moonlight Therapeutics Inc., Allero Therapeutics B.V., Sanofi, Johnson & Johnson, Viatris Inc. (Mylan N.V.), Sun Pharmaceutical Industries Ltd., Bayer AG, Aurobindo Pharma Limited., Astellas Pharma Inc., Siolta Therapeutics, DESENTUM OY, ALK, Immunomic Therapeutics, Inc., and Stallergenes Greer Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The North America, Europe, and Australia peanut allergy treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the North America, Europe, and Australia peanut allergy treatment market.

Detailed Segmentation:

North America, Europe, and Australia Peanut Allergy Treatment Market, By Drug Type :
- Epinephrine
- Antihistamine
  - Loratadine
  - Diphenhydramine
  - Others
- Palforzia
- Pipeline Drugs
  - Viaskin Peanut
  - Ligelizumab
  - CA002
  - PRT120
  - Dupilumab
North America, Europe, and Australia Peanut Allergy Treatment Market, By Route of Administration :
- Oral
- Parenteral
- Intranasal
- Epicutaneous
North America, Europe, and Australia Peanut Allergy Treatment Market, By Distribution Channel :
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
North America, Europe, and Australia Peanut Allergy Treatment Market, By Region:
- North America
  - By Country
    - U.S.
    - Northeast
    - Southwest
    - West
    - Southeast
    - Midwest
    - Canada
- Europe
  - By Country
    - France
    - Italy
    - Spain
    - Switzerland
    - Netherlands
    - Austria
    - Czech & Slovakia
    - Rest of Europe
    - Australia
Company Profiles
- DBV Technologies.*
  - Company Highlights
  - Products Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Aimmune Therapeutics, Inc.
- Prota Therapeutics Pty Ltd.
- COUR Pharmaceuticals
- BlueWillow Biologics
- HAL Allergy B.V.
- Allergy Therapeutics PLC.
- Novartis AG
- Regeneron Pharmaceuticals, Inc.
- Vedanta Biosciences, Inc.
- Cambridge Allergy Ltd. (Camallergy)
- Angany Inc.
- Moonlight Therapeutics Inc.
- Allero Therapeutics B.V.
- Sanofi
- Johnson & Johnson
- Viatris Inc. (Mylan N.V.)
- Sun Pharmaceutical Industries Ltd.
- Bayer AG
- Aurobindo Pharma Limited.
- Astellas Pharma Inc.
- Siolta Therapeutics
- DESENTUM OY
- ALK
- Immunomic Therapeutics, Inc.
- Stallergenes Greer Ltd.

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snapshot, By Drug Type
  - Market Snapshot, By Route of Administration
  - Market Snapshot, By Distribution Channels
  - Market Snapshot, By Region
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Drivers
  - Restraints
  - Opportunity
- Impact Analysis
- Key developments
- Pipeline Analysis
- Collaborations and Agreements
- Market Trends
- Product Approval
- Regulatory Scenario
- PEST Analysis
- PORTER’s Five Forces Analysis
- Reimbursement Scenario
- Prescriber Preference: Overview
- Prescriber Overview
- Treatment Algorithm
- Epidemiology
North America Europe and Australia Peanut Allergy Treatment Market – Impact of Coronavirus (COVID-19) Pandemic
- Economic Impact
- Impact on Peanut Allergy Treatment Market
- COVID-19 Epidemiology
North America Europe and Australia Peanut Allergy Treatment Market, By Drug Type, 2017-2030, (US$ Mn)
- Introduction
  - Market Share Analysis, 2022 and 2030 (%)
  - Y-o-Y Growth Analysis, 2018 – 2030
  - Segment Trends
- Epinephrine
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
- Antihistamine
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
    - Loratadine
    - Diphenhydramine
    - Others
  - Palforzia
    - Introduction
    - Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
  - Pipeline Drugs
    - Introduction
    - Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
      - Viaskin Peanut
      - Ligelizuma
      - CA002
      - PRT120
      - Dupilumab
North America Europe and Australia Peanut Allergy Treatment Market, By Route of Administration, 2017-2030, (US$ Mn)
- Introduction
  - Market Share Analysis, 2022 and 2030 (%)
  - Y-o-Y Growth Analysis, 2018 – 2030
  - Segment Trends
- Oral
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
- Parenteral
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
- Intranasal
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
- Epicutaneous
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
North America Europe and Australia Peanut Allergy Treatment Market, By Distribution Channel, 2017-2030, (US$ Mn)
- Introduction
  - Market Share Analysis, 2022 and 2030 (%)
  - Y-o-Y Growth Analysis, 2018 – 2030
  - Segment Trends
- Hospital Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
- Retail Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
- Online Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
North America Europe and Australia Peanut Allergy Treatment Market, By Region, 2017-2030, (US$ Mn)
- Introduction
  - Market Share Analysis, By Region, 2022 and 2030 (%)
  - Y-o-Y Growth Analysis, For Regions, 2018–2030
  - Regional Trends
- North America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017-2030,(US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017-2030,(US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017-2030,(US$ Mn)
    - U.S.
      - Introduction
      - Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017-2030,(US$ Mn)
      - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017-2030,(US$ Mn)
      - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn)
      - Market Size and Forecast, and Y-o-Y Growth, By Sub-region, 2017-2030,(US$ Mn)
    - Northeast
      - Introduction
      - Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017-2030,(US$ Mn)
      - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017-2030,(US$ Mn)
      - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn)
    - Southwest
      - Introduction
      - Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017-2030,(US$ Mn)
      - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017-2030,(US$ Mn)
      - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn)
    - West
      - Introduction
      - Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017-2030,(US$ Mn)
      - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017-2030,(US$ Mn)
      - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn)
    - Southeast
      - Introduction
      - Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017-2030,(US$ Mn)
      - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017-2030,(US$ Mn)
      - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn)
    - Southeast
      - Introduction
      - Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017-2030,(US$ Mn)
      - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017-2030,(US$ Mn)
      - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn)
    - Midwest
      - Introduction
      - Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017-2030,(US$ Mn)
      - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017-2030,(US$ Mn)
      - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn)
    - Canada
      - Introduction
      - Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017-2030,(US$ Mn)
      - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017-2030,(US$ Mn)
      - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn)
- Europe
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017-2030,(US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017-2030,(US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017-2030,(US$ Mn)
    - U.K.
      - Introduction
      - Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017-2030,(US$ Mn)
      - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017-2030,(US$ Mn)
      - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn)
    - Germany
      - Introduction
      - Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017-2030,(US$ Mn)
      - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017-2030,(US$ Mn)
      - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn)
    - France
      - Introduction
      - Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017-2030,(US$ Mn)
      - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017-2030,(US$ Mn)
      - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn)
    - Italy
      - Introduction
      - Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017-2030,(US$ Mn)
      - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017-2030,(US$ Mn)
      - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn)
    - Spain
      - Introduction
      - Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017-2030,(US$ Mn)
      - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017-2030,(US$ Mn)
      - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn)
    - Switzerland
      - Introduction
      - Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017-2030,(US$ Mn)
      - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017-2030,(US$ Mn)
      - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn)
    - Netherlands
      - Introduction
      - Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017-2030,(US$ Mn)
      - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017-2030,(US$ Mn)
      - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn)
    - Austria
      - Introduction
      - Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017-2030,(US$ Mn)
      - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017-2030,(US$ Mn)
      - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn)
    - Czech & Slovakia
      - Introduction
      - Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017-2030,(US$ Mn)
      - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017-2030,(US$ Mn)
      - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn)
    - Rest of Europe
      - Introduction
      - Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017-2030,(US$ Mn)
      - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017-2030,(US$ Mn)
      - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn)
- Australia
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017-2030,(US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017-2030,(US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn)
Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
  - DBV Technologies*
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Aimmune Therapeutics, Inc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Prota Therapeutics Pty Ltd
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - COUR Pharmaceuticals
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - BlueWillow Biologics
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - HAL Allergy B.V
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Allergy Therapeutics PLC
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Novartis AG
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Regeneron Pharmaceuticals, Inc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Vedanta Biosciences, Inc
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Cambridge Allergy Ltd. (Camallergy)
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Angany Inc
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Moonlight Therapeutics Inc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Moonlight Therapeutics Inc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Allero Therapeutics B.V.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Sanofi
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Johnson & Johnson
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Viatris Inc. (Mylan N.V.)
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Sun Pharmaceutical Industries Ltd
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Bayer AG
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Aurobindo Pharma Limited.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Astellas Pharma Inc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Astellas Pharma Inc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Siolta Therapeutics
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - DESENTUM OY
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - ALK
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Immunomic Therapeutics, Inc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Stallergenes Greer Ltd
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
Section
- Research Methodology
- About Us and Services
- Contact

*Browse 75 market data tables and 39 figures on "North America Europe and Australia Peanut Allergy Treatment Market” - Forecast to 2030

View Our Licence Options

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail
Request Discount